Regulated Information

26 results have been found

Advanced search
Categories
Years
Number of results
1 2 3 | »
Press releases

DBV Technologies Reports March 31, 2017 Cash Position

Outstanding shares and voting rights statements | Press releases

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

DBV Technologies to Attend the 10th Kempen Life Sciences Conference

Press releases

DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination

Annual Financial reports | Internal control and corporate governance reports | Share buyback Programs | Press releases

DBV Technologies Announces Filing of its 2016 “Document de Référence” and Annual Report on Form 20-F

Annual Financial reports | Internal control and corporate governance reports | Share buyback Programs | Press releases

20F- Form 2016

Press releases

DBV Technologies Reports Full Year 2016 Financial Results

Press releases

DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children

Outstanding shares and voting rights statements

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Press releases

Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children

1 2 3 | »